Valuation: UCB

Market Cap 4.64TCr 5.3TCr 4.3TCr 3.96TCr 7.47TCr 5,10200Cr 7.56TCr 51TCr 20TCr 2,50000Cr 20TCr 19TCr 8,63300Cr P/E 2026 *
25.5x
P/E 2027 * 20.2x
Enterprise Value 4.62TCr 5.27TCr 4.28TCr 3.94TCr 7.43TCr 5,07500Cr 7.52TCr 51TCr 20TCr 2,48700Cr 20TCr 19TCr 8,58800Cr EV / Sales 2026 *
5.41x
EV / Sales 2027 * 4.57x
Free-Float
61.59%
Yield 2026 *
0.62%
Yield 2027 * 0.63%
Manager TitleAgeSince
Chief Executive Officer 67 01/01/2015
Director of Finance/CFO 59 01/07/2020
Chief Tech/Sci/R&D Officer 59 01/05/2024
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Director/Board Member 67 01/01/2015
Director/Board Member 56 24/04/2014
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-.--% - - 5.17TCr
+0.40%+2.90%+23.76%-8.10% 6.84TCr
+3.72%+39.50%+39.50%+39.50% 4.21TCr
-1.00%+0.03%-52.84%-54.25% 4.11TCr
+1.35%+5.73%+65.43%-26.67% 2.95TCr
+0.08%-11.87%+91.92%-52.99% 2.36TCr
+1.48%+2.59%+74.92%+83.73% 2.31TCr
-0.38%+3.42%+3.48%+194.88% 2.05TCr
+0.43%+2.42%+72.86%+123.13% 1.65TCr
+1.57%-2.38%+78.83%+140.51% 1.58TCr
Average +0.76%-1.03%+44.21%+48.86% 3.12TCr
Weighted average by Cap. +0.69%-0.43%+33.74%+25.07%

Financials

2026 *2027 *
Net sales 854.34Cr 974.72Cr 791.61Cr 728.6Cr 1.37TCr 94TCr 1.39TCr 9.45TCr 3.7TCr 46TCr 3.66TCr 3.58TCr 1,58800Cr 964.37Cr 1.1TCr 893.56Cr 822.44Cr 1.55TCr 1,06000Cr 1.57TCr 11TCr 4.17TCr 52TCr 4.13TCr 4.04TCr 1,79300Cr
Net income 177.01Cr 201.95Cr 164.01Cr 150.95Cr 284.65Cr 19TCr 288.1Cr 1.96TCr 765.98Cr 9.53TCr 758.06Cr 741.75Cr 33TCr 227.71Cr 259.8Cr 210.99Cr 194.2Cr 366.2Cr 25TCr 370.63Cr 2.52TCr 985.41Cr 12TCr 975.23Cr 954.24Cr 42TCr
Net Debt -24Cr -28Cr -22Cr -21Cr -39Cr -2.66TCr -39Cr -267.85Cr -104.81Cr -1.3TCr -103.73Cr -101.5Cr -4.5TCr -232.32Cr -265.06Cr -215.26Cr -198.13Cr -373.61Cr -26TCr -378.13Cr -2.57TCr -1.01TCr -13TCr -994.97Cr -973.55Cr -43TCr
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA